Advanced mesenchymal stem cell therapy and neuromodulatory regenerative support for trigeminal neuralgia and chronic facial nerve pain at our clinic in Istanbul.
Facial nerve pain · Neuropathic pain attacks · Neuroinflammation support · Chronic facial pain · Neurology-aware evaluation
How treatment is delivered
For neurological conditions the route matters as much as the product. Your physician may combine intrathecal, intravenous and intranasal delivery in a single program, chosen after reviewing your history, imaging and goals.
A physician places the preparation into the cerebrospinal fluid through a fine needle at the lower back, under sterile conditions. That fluid surrounds the spinal cord and the brain, which is why this route is central to these programs.
Stem cells and exosomes are given as a calm, monitored infusion. The circulation carries them through the body, where they are studied for their signalling and immune-modulating effects.
Exosomes are also given as a nasal spray. The route is studied because the olfactory nerve offers a short pathway toward the brain, and it needs no needle at all.
Your care, the science, your goals
Follow a visual journey from your assessment to the biological ideas being explored. These silent, illustrative films help you prepare for a personal conversation about care in Istanbul.
01 Your assessment
A conversation about trigeminal neuralgia begins with your health history, current care and what you hope to improve. Our Istanbul team can help you explore the next step in an individual medical review.
The scene introduces the subject of your assessment. Your own examination, investigations and care plan will be individual to you.
02 Inside the concept
The nervous system depends on communication between nerve cells and their surrounding support cells. Researchers investigate this environment, including inflammation and cellular signals. These ideas are distinct from evidence that a treatment restores neurological function.
03 Your goals
Talk to us about the activities, comfort and wellbeing that matter most to you. A useful consultation connects those personal goals with realistic options, the available evidence and a clear plan for follow-up.
Discuss possible benefits, risks, alternatives and the possibility of no improvement before deciding.
Your questions deserve a personal answer.
Trigeminal neuralgia (TN) is one of the most severe neuropathic pain conditions known. It affects the trigeminal nerve, also called cranial nerve V, and is characterized by sudden, shock-like bursts of facial pain that can be triggered by completely normal activities such as speaking, brushing teeth, eating, washing the face, or feeling a cool breeze.
For many patients, the pain is not merely uncomfortable. It is disabling. The unpredictability of attacks can create fear around eating, hygiene, conversation, and daily life itself. Some patients also develop lingering background facial pain, sensory discomfort, medication fatigue, and significant emotional strain.
Conventional treatment may include carbamazepine, oxcarbazepine, other neuropathic pain medication, and in selected cases procedures such as microvascular decompression or radiosurgery. Many patients begin exploring mesenchymal stem cell therapy because they want to know whether chronic trigeminal nerve irritation and pain-cycle signaling can be approached more broadly.
Trigeminal neuralgia is not a simple toothache or sinus problem. It is a neuropathic nerve-pain condition with several possible biological drivers:
Trigeminal neuralgia is not typical facial pain. It is a cranial neuropathic pain condition involving abnormal trigeminal nerve signaling.
Pain may arise from vascular compression, myelin damage, prior intervention, multiple sclerosis, or other chronic trigeminal nerve stressors.
Over time, repeated attacks may contribute to a more sensitized nervous system and increasingly disruptive pain patterns.
TN affects eating, speaking, hygiene, social comfort, and psychological wellbeing in ways that many outsiders underestimate.
Patients seeking trigeminal neuralgia stem cell therapy in Turkey often describe far more than facial pain alone:
Trigeminal neuralgia often causes sudden, stabbing, shock-like bursts of pain that can feel unbearable and may stop patients mid-sentence or mid-activity.
Pain may be triggered by chewing, brushing teeth, washing the face, speaking, wind exposure, or even light touch in the affected area.
Many patients rely on medications such as carbamazepine or oxcarbazepine, but side effects and incomplete control often become a major problem.
The unpredictability and severity of facial pain can deeply affect sleep, confidence, mood, social activity, and normal daily functioning.
Mesenchymal stem cells (MSCs) are studied for trigeminal neuralgia because they may influence several pathways relevant to chronic nerve irritation and neuropathic pain. The goal is not to claim a cure, but to explore whether the nerve environment can become less inflammatory, less sensitized, and more biologically stable.
One of the main reasons patients explore stem cell therapy for trigeminal neuralgia is the possibility of reducing inflammatory and irritative signals around the trigeminal nerve and its pathways.
MSCs are studied because they may influence neuropathic pain signaling, sensitization patterns, and the broader environment in which aberrant nerve firing is sustained.
Patients are often interested in whether regenerative signaling may support nerve integrity, myelin-related stability, and a reduction in chronic pain-cycle perpetuation over time.
Submit your neurological notes, MRI reports, medication history, pain pattern, and prior procedure records for a free evaluation by our neurology-aware team in Istanbul.
Patients usually inquire because they are trying to solve several problems at once: unbearable pain attacks, medication side effects, lifestyle limitations, sleep disruption, and fear of triggers.
Patients often explore regenerative therapy because chronic nerve irritation and inflammatory signaling may contribute to persistent pain cycles.
A major reason for interest is whether the nerve environment can be calmed and supported rather than only masked with medication.
Patients frequently hope for fewer attacks, lower attack intensity, and less hypersensitivity to everyday triggers.
The goal is often not only pain reduction, but also improved sleep, function, confidence, and reduced dependence on heavy medication.
Eligibility depends on the suspected cause of the pain, disease duration, imaging, prior treatment history, and overall neurological context:
Patients looking for trigeminal neuralgia treatment in Turkey often want neurology-aware review, regenerative medicine access, easier travel logistics, and a more favorable private-treatment cost structure.
Trigeminal neuralgia cases benefit from review of MRI findings, medication history, trigger pattern, prior procedures, and branch distribution.
Our protocols are designed for patients seeking stem cell and exosome-based neuromodulatory support for chronic neuropathic facial pain.
Istanbul offers strong private medical infrastructure and accessible travel routes for international neurology and pain patients.
Turkey often offers a substantial cost advantage compared with many Western private regenerative medicine programs.
Stem cell and exosome therapy for trigeminal neuralgia is best understood as a supportive regenerative option, not a guaranteed cure. Even when MRI and clinical history suggest a reasonable biological case, outcomes are individual and depend on the underlying cause (classical neurovascular compression, demyelinating, post-traumatic, or idiopathic), the duration and severity of the pain pattern, the level of underlying neuroinflammation, the patient's age, comorbidities, and previous treatment history including medications, blocks, or surgical interventions. Every candidate is reviewed individually before treatment in Istanbul.
Most patients tolerate IV and locally administered regenerative procedures well, but it is honest to share the realistic short-term effects so expectations are set clearly. Depending on the route used in the protocol, the following may occur:
Serious adverse events are uncommon under medical supervision with properly screened cell products, but no procedure is risk-free. Regenerative therapy does not replace urgent care, prescribed neuropathic-pain medication, microvascular decompression or other surgery when clearly indicated, or specialist neurology follow-up. It should be understood as part of a broader care plan. Patients are encouraged to continue care with their home physician and to review our patient journey, clinical studies, and FAQ resources, so the decision to travel for treatment is made with realistic, well-informed expectations.
Stem cell therapy for trigeminal neuralgia is investigational. Results vary and are not guaranteed. Treatment does not replace neurological care, pain management, medication review, or neurosurgical consultation when indicated.
Explore related regenerative medicine approaches and learn more about our clinic, research, and patient support.
Submit your neurological records and imaging for a free evaluation by our Istanbul pain management team.
Or call directly: +90 534 856 92 92
Optional analytics is off until you choose.
May we use Google Analytics cookies to count interactions such as consultation requests and contact-button clicks? Your choice is optional and does not affect access to our services. You can change it here at any time. Read our privacy policy.
